Source: International Congress 2016 – Clinical aspects of lung cancer
Disease area: Thoracic oncology



Rating:

Share or cite this content

Citations should be made in the following way:
Luis Alejandro Padron Fraysse (Sevilla, Spain), Luis Alejandro Padron Fraysse, Beatriz Romero Romero, Lourdes Gómez Izquierdo, Maria Fondillón Alberdi, Jose Martin Juan. Profile of non-neoplasic mediastinal lymph nodes (NNLN) during the study of lung cáncer (LC). Eur Respir J 2016; 48: Suppl. 60, 2817

Member's Comments

No comment yet.

Related content which might interest you: Mediastinal lymph nodes (MLN) vascular pattern utilitiy to predict progression in lung cancer Source: International Congress 2014 – Diagnosis, imaging and surgery for thoracic tumours Year: 2014 Myeloid antigen presenting cells in lung adenocarcinoma lymph nodes assessed by endobronchial ultrasound Source: International Congress 2016 – Endosonography: EBUS/EUS (B) Year: 2016 Elastography strain ratio in the staging of mediastinal lymph nodes Source: International Congress 2014 – EBUS-TBNA: beyond the tracheobronchial wall Year: 2014 Regulatory vs. cytotoxic cells in lymph nodes of lung cancer patients resected by TEMLA Source: International Congress 2016 – Lung cancer immunology: latest research Year: 2016 Ultrasound guided true cut biopsy of peripheral lymph nodes as a staging procedure in patients with non-small cell lung cancer (NSCLC) Source: International Congress 2016 – EBUS and transthoracic ultrasound Year: 2016 The prevalence of metastasis to the aortopulmonary window lymph nodes (stations 5 and 6) in patients with left lung carcinoma: A retrospective analysis of 566 patients Source: Annual Congress 2013 –Oncological thoracic surgery Year: 2013 Ultrasonographic evaluation of mediastinal lymph nodes using endobronchial ultrasound Source: Annual Congress 2013 –TBNA, EBUS-TBNA and new technologies for diagnostic bronchoscopy Year: 2013 Endobronchial ultrasound elastography type classification in the diagnosis of mediastinal and hilar lymph nodes Source: International Congress 2015 – Endoscopic ultrasound: an essential tool for interventional pulmonology Year: 2015 Multigene mutation analysis of mediastinal and hilar lymph nodes sampled by endobronchial unltrasound-guided needle aspiration Source: Annual Congress 2013 –Biology and molecular pathology of lung cancer Year: 2013 Role of the EBUS-EUS-FNA combined approach by using single ultrasound bronchoscope for tissue diagnosis in mediastinal lymphadenopathy Source: International Congress 2014 – Improving diagnosis of thoracic tumours Year: 2014 PET and endobronchial ultrasound. SUV value of mediastinal lymph nodes suspicious for malignancy Source: International Congress 2015 – Mediastinal tumors, malignant pleural mesothelioma and other rare tumors Year: 2015 Endobronchial ultrasound elastography for the prediction of malignant intrathoracic lymph nodes during EBUS-TBNA Source: International Congress 2016 – Endosonography: EBUS/EUS (B) Year: 2016 Improved negative predictive value of EBUS-TBNA in isolated mediastinal / hilar lymphadenopathy: Why and what it means for patients? Source: Annual Congress 2013 –TBNA, EBUS-TBNA and new technologies for diagnostic bronchoscopy Year: 2013 Is there agreement for optimal transbronchial sampling positions in lymph nodes? Source: International Congress 2014 – EBUS-TBNA: beyond the tracheobronchial wall Year: 2014 Analysis of FOXP3 expression in the lymph nodes of patients with lung adenocarcinoma- The pilot study Source: International Congress 2015 – Cell biology of lung cancer and new biomarkers Year: 2015 Correlation of FDG-PET/CT and EBUS-TBNA for nodal staging in lung cancer Source: Annual Congress 2013 –New methods for diagnostic workup of lung cancer Year: 2013 EUS-B-FNA vs EUS-FNA for left adrenal gland analysis in lung cancer patients Source: International Congress 2016 – Endosonography: EBUS/EUS (B) Year: 2016 Patient and procedure determinants of EBUS-TBNA accuracy in mediastinal staging of lung cancer Source: Annual Congress 2013 –Progress in bronchoscopy and pathology techniques for diagnosis of thoracic malignancies Year: 2013 Is primary tumor metabolic activity a risk factor for occult lymph node metastasis in T1-2N0M0 non-small cell lung cancer patients? Source: International Congress 2014 – Diagnosis, imaging and surgery for thoracic tumours Year: 2014 Comparing performance and cost of EBUS-TBNA versus other methods for diagnosis and staging of non-small cell lung cancer (NSCLC) Source: International Congress 2014 – Improving diagnosis of thoracic tumours Year: 2014